封面
市場調查報告書
商品編碼
2170202

血液透析導管市場機會、成長要素、產業趨勢分析及2026-2035年預測

Hemodialysis Catheters Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

出版日期: | 出版商: Global Market Insights Inc. | 英文 194 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年,血液透析導管市場規模將超過 10.6 億美元,年複合成長率為 6.9%,到 2035 年將達到 20.6 億美元。

這些裝置為腎臟替代療法提供血管通路,並有多種配置可供選擇,例如即時用型和長期使用型。採購趨勢反映了醫療服務提供者的需求,例如是否需要啟動透析、是否需要永久性通路、是否能確保可靠的血流、是否易於插入以及是否與既定的導管管理方案相容。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 10.6億美元
預計金額 20.6億美元
複合年成長率 6.9%

末期腎病持續推動醫院和門診透析服務機構的導管採購。成熟的腎臟護理系統透過接受治療的患者持續購買導管,而隨著更多患者進入正規透析流程,不斷擴張的系統也增加了導管需求。亞太地區基礎設施的建設促進了透析網路的批量採購,而持續的報銷和不斷增加的設施也影響著患者獲得治療的機會。在動靜脈瘻管或移植血管可用之前,當需要透析時,導管也發揮「橋樑」的作用。轉診、血管通路規劃和動靜脈瘻管成熟的延遲會延長透析需求,從而推高了對急性照護導管和隧道導管的需求。在產品開發方面,透過適用於感染控制措施的導管尖端設計和抗菌表面技術,正在建立以價值為導向的採購管道。醫療服務提供者重視這些特性,以及血流可靠性和插入效率。因此,商業性機會結合了持續的血管通路需求和選擇性升級,導管性能和標準化護理方案會影響醫療服務提供者的採購決策。

根據導管類型,預計到2025年,長期血液透析導管的市場規模將達到6.38億美元。部分患者在急性治療期後仍需維持血管通路,因此需要能支持長期使用的導管。安全形成血管通路和易於操作的置入是其適用性的關鍵因素,尤其是在門診透析中。在永久性血管通路尚未普及的情況下,這些產品將繼續發揮至關重要的作用。進入該領域的供應商需要根據臨床操作和醫療機構的工作流程來調整導管的特性,而不僅僅是強調使用時間長度。可靠的血管通路和持續透析的實際需求是推動採購的主要因素,而醫療機構的偏好和既定的導管護理規範則影響著該長期使用產品類型中的選擇。

單獨來看,帶袖隧道導管預計到2025年銷售額將達4.36億美元。袖套周圍的組織生長有助於導管的穩定性,並能有效阻止污染物在導管內擴散。這些特性使其適用於計畫內的長期通路。然而,實際應用的可行性仍取決於現有的手術能力、個別解剖結構以及透析中心的偏好。客戶會根據導管插入和護理操作來評估產品,這些操作和操作需要支援持續治療。因此,在商業性提案中,導管的設計及其在長期使用中的通路管理能力是緊密相關的。當醫療機構優先考慮計劃內的導管插入路徑以及與既定感染預防措施的兼容性時,供應商可以透過提供合適的配置和可靠的性能來贏得競爭優勢。

預計2025年,北美血液透析導管市場規模將達到4.46億美元。成熟的透析服務和完善的保險報銷系統為大規模腎臟護理機構和醫院的採購提供了支援。儘管通路規劃和感染監測會影響需求,但醫療保健採購仍需可靠的供應和臨床證據。供應商必須滿足標準化的選擇標準,而不能僅依賴醫生的偏好或產品的新穎性。與主要醫療機構和採購組織建立關係對於確定客戶管道至關重要。因此,該地區的商業機會受制於持續的治療需求和正式的評估流程,供應商競相滿足導管的性能要求和成熟透析網路的營運預期。

預計到2025年,Teleflex將佔據約19%的市場。其「Arrow」血管通路產品系列可滿足急性和慢性導管需求,產品注重抗菌性能和卓越表現。公司憑藉其在血管通路領域的專業知識和廣泛的醫院網路,確保能夠透過多種採購管道獲得產品。其專注於血管通路業務的產品組合策略,凸顯了導管領域創新和執行力的商業性重要性。憑藉其穩固的業務基礎,Teleflex能夠滿足客戶當前和持續的血管通路需求,並佔據市場領先地位。客戶在評估醫療設備性能和醫療機構供應鏈時,可以將Teleflex豐富的產品線納入更廣泛的採購決策考量,其中,證據、產品範圍和可靠的生產能力都會影響供應商的選擇。

市場的主要參與者包括BD、B. Braun、AngioDynamics、Baxter、Cook Medical、Mozarc Medical、Merit Medical、Vygon、Medcomp、Healthline Medical Products、ST Stone Medical、Bain Medical Equipment、Delta Med、Polymed和Amecath。 BD透過其多樣化的導管設計和國際分銷網路,滿足急性和慢性血管通路需求。 B. Braun將血管通路與廣泛的腎臟護理產品相結合,而專業公司則專注於血流性能、介入應用和區域性需求。區域性競爭對手透過縮短供應鏈和提供具有成本效益的產品,在價格和供應方面保持競爭力。醫院評估團隊、採購集團和透析網路在選擇導管供應商時,會考慮產品的科學基礎、感染控制措施、生產可靠性以及與供應商的廣泛合作關係。

目錄

第1章:調查方法

第2章執行摘要

第3章 行業洞察

  • 產業生態系分析
  • 影響產業的因素
    • 促進因素
      • 慢性腎臟病和末期腎功能衰竭的盛行率增加
      • 支持旨在提高公眾對慢性腎臟病意識的措施
      • 尋求腎臟替代療法的患者人數增加
      • 血液透析導管的技術進步
      • 全球腎臟捐贈者短缺
    • 產業潛在風險與挑戰
      • 對腎臟相關疾病的認知不足
      • 血液透析導管相關併發症
    • 市場機遇
      • 擴大居家透析和遠端患者監護解決方案
      • 擴大抗菌和生物相容性導管材料的應用。
      • 新興市場在醫療基礎建設方面具有成長潛力。
  • 成長潛力分析
  • 價格分析
    • 對過去價格趨勢的分析
    • 依球員類型分類的定價策略(高級球員、超值球員、成本加成球員)
  • 監理情勢
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 技術展望
    • 最新科技趨勢
    • 新興技術
  • 未來市場趨勢
  • 波特的分析
  • PESTLE分析
  • 貿易數據分析
    • 進出口量及進口額趨勢
    • 主要貿易路線及關稅的影響
  • 人工智慧和生成式人工智慧對市場的影響
    • 利用人工智慧改造現有經營模式
    • 按細分市場分類的生成式人工智慧用例和部署藍圖
    • 風險、限制和監管考量
  • 差距分析
  • 專利/智慧財產權 (IP) 的發展趨勢
  • 目前醫療基礎設施狀況
  • 流行病學/疾病負擔

第4章 競爭情勢

  • 介紹
  • 企業市佔率分析
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區
      • 拉丁美洲
      • 中東和非洲
    • 市場集中度分析
  • 主要市場公司的競爭分析
  • 競爭定位矩陣
  • 主要進展
    • 併購
    • 夥伴關係和聯盟
    • 新產品發布
    • 業務拓展計劃及資金籌措
  • 按公司規模進行基準測試
    • 排名分類標準與遴選標準
    • 按銷售額、地區和創新能力分類的層級定位矩陣。

第5章 市場估算與預測:依導管類型分類,2026-2035年

  • 用於長期血液透析的導管
  • 短期血液透析導管

第6章 市場估算與預測:依產品分類,2026-2035年

  • 隧道式導管
    • 附袖隧道導管
    • 無袖隧道導管
  • 非隧道導管

第7章 市場估計與預測:依材料分類,2026-2035年

  • 聚氨酯
  • 矽酮

第8章 市場估算與預測:依晶片配置分類,2026-2035年

  • 分叉導管
  • 階梯尖端導管
  • 對稱導管
  • 其他晶片配置

第9章 市場估算與預測:以流明計算,2026-2035年

  • 雙流明
  • 單流明
  • 三流明

第10章 市場估價與預測:依地區分類,2026-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 其他中東和非洲國家

第11章:公司簡介

  • Global Player
    • B. Braun
    • Baxter
    • Becton, Dickinson and Company(BD)
    • Cook Medical
    • Merit Medical
    • Teleflex
    • Vygon
    • AngioDynamics
  • Regional Player
    • Amecath
    • Bain Medical Equipment
    • Delta Med
    • Healthline Medical Products
    • Medcomp
    • Polymed
  • Emerging Player
    • Mozarc Medical
    • ST Stone Medical
簡介目錄
Product Code: 5264

The Hemodialysis Catheters Market exceeded USD 1.06 billion in 2025 and is projected to grow at 6.9% CAGR to reach USD 2.06 billion by 2035. Devices provide vascular access for renal replacement therapy, including immediate-use and longer-term configurations. Purchasing reflects dialysis initiation, availability of permanent access, and providers' requirements for dependable flow, practical insertion, and compatibility with established catheter-care protocols.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$1.06 Billion
Forecast Value$2.06 Billion
CAGR6.9%

End-stage kidney disease sustains catheter procurement across hospitals and outpatient dialysis services. Established renal-care systems generate recurring purchasing from patients already receiving treatment, while expanding systems add demand as more patients enter formal dialysis pathways. Asia Pacific infrastructure growth supports bulk procurement by dialysis networks, with reimbursement continuity and additional centers influencing access to treatment. Catheters also serve as a bridge when dialysis is required before a fistula or graft can be used. Delayed referral, access planning, and fistula maturation can extend that need, supporting both acute and tunneled configurations. Product development adds a value-driven purchasing channel through tip design and antimicrobial surface technologies suited to infection-control practice. Facilities evaluate these features alongside flow reliability and insertion efficiency. The commercial opportunity consequently combines persistent access requirements with selective upgrades where catheter performance and standardized care protocols influence institutional buying decisions.

Based on catheter type, long-term hemodialysis catheters contributed USD 638 million in 2025. Patients requiring access beyond an acute treatment period create a role for devices that can support extended use. Secure tunneling and manageable dwell performance influence their suitability, particularly in outpatient dialysis. These products remain relevant while permanent vascular access is unavailable. Suppliers serving the segment need to align device characteristics with clinical handling and provider workflows rather than emphasize duration alone. Dependable access and the practical requirements of ongoing dialysis support purchasing, while facility preferences and established catheter-care approaches shape selection within this longer-term product category.

By product, cuffed tunneled catheters contributed revenue of USD 436 million in 2025. Tissue growth around the cuff helps stabilize the device and provides a barrier to contamination moving along the catheter. These properties support use in planned longer-term access pathways. Adoption still depends on the procedure capabilities available, individual anatomy, and dialysis-center preferences. Customers evaluate the product within insertion and care practices that must support continued treatment. The commercial proposition therefore connects device design with the ability to manage access over extended use. Suppliers can compete through suitable configurations and reliable performance where providers prioritize planned catheter pathways and compatibility with established infection-prevention routines.

The North America hemodialysis catheters market contributed USD 446 million in 2025. Mature dialysis services and established reimbursement support purchasing by large renal-care organizations and hospitals. Access planning and infection surveillance influence demand, while institutional procurement creates requirements for dependable supply and clinical evidence. Vendors must meet standardized selection criteria rather than rely solely on physician preference or product novelty. Relationships with major care providers and purchasing organizations help determine account access. The regional opportunity is consequently shaped by recurring treatment needs and formal evaluation processes, with suppliers competing to satisfy both catheter performance requirements and the operational expectations of established dialysis networks.

Teleflex held approximately 19% market share in 2025. Its Arrow vascular-access range covers acute and chronic catheter needs alongside antimicrobial and performance-oriented offerings. The company combines vascular-access knowledge with broad hospital reach, giving it access to several procurement settings. Portfolio actions focusing attention on businesses that include vascular access reinforce the commercial importance of catheter innovation and execution. Its position reflects the ability to serve immediate and continuing access requirements through an established franchise. Customers evaluating device performance and institutional supply can consider this breadth within broader purchasing decisions, where evidence, product range, and dependable manufacturing influence supplier selection.

Some of the major players in this market are BD, B. Braun, AngioDynamics, Baxter, Cook Medical, Mozarc Medical, Merit Medical, Vygon, Medcomp, Healthline Medical Products, ST Stone Medical, Bain Medical Equipment, Delta Med, Polymed, and Amecath. BD serves acute and chronic access through varied catheter designs and international distribution. B. Braun connects vascular access with a wider renal-care portfolio, while specialist companies address flow performance, interventional use, and local requirements. Regional competitors sustain price and availability competition through shorter supply chains and cost-conscious offerings. Hospital evaluation teams, purchasing groups, and dialysis networks consider product evidence, infection-control positioning, manufacturing reliability, and broader supplier relationships when choosing catheter providers.

Table of Contents

Chapter 1. Research Methodology

  • 1.1 Research approach
  • 1.2 Quality Commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research Trail & Confidence Scoring
    • 1.3.1 Research Trail Components
    • 1.3.2 Scoring Components
  • 1.4 Data Collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2. Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Catheter type trends
    • 2.2.2 Product trends
    • 2.2.3 Material trends
    • 2.2.4 Tip configuration trends
    • 2.2.5 Lumen trends
    • 2.2.6 Regional trends
  • 2.3 TAM Analysis, 2027 - 2035
  • 2.4 CXO perspectives: strategic imperatives

Chapter 3. Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of chronic kidney disorders and end-stage renal disease
      • 3.2.1.2 Facilitative initiatives to promote chronic kidney disorder awareness
      • 3.2.1.3 Rising number of renal replacement therapy
      • 3.2.1.4 Technological advancements in hemodialysis catheters
      • 3.2.1.5 Shortage of kidney donors globally
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Low awareness about kidney-related disorders
      • 3.2.2.2 Complications associated with hemodialysis catheters
    • 3.2.3 Market opportunities
      • 3.2.3.1 Expansion of home-based dialysis and remote patient monitoring solutions
      • 3.2.3.2 Increasing adoption of antimicrobial and biocompatible catheter materials
      • 3.2.3.3 Growth potential in emerging markets with rising healthcare infrastructure
  • 3.3 Growth potential analysis
  • 3.4 Pricing analysis (Driven by Primary Research)
    • 3.4.1 Historical Price Trend Analysis
    • 3.4.2 Pricing Strategy by Player Type (Premium / Value / Cost-plus)
  • 3.5 Regulatory landscape
    • 3.5.1 North America
    • 3.5.2 Europe
    • 3.5.3 Asia-Pacific
    • 3.5.4 Latin America
    • 3.5.5 Middle East and Africa
  • 3.6 Technology landscape
    • 3.6.1 Current technological trends
    • 3.6.2 Emerging technologies
  • 3.7 Future market trends
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Trade Data Analysis (Based on Paid Database)
    • 3.10.1 Import/Export Volume & Value Trends
    • 3.10.2 Key Trade Corridors & Tariff Impact
  • 3.11 Impact of AI & Generative AI on the Market (Driven by Primary Research)
    • 3.11.1 AI-Driven Disruption of Existing Business Models
    • 3.11.2 GenAI Use Cases & Adoption Roadmap by Segment
    • 3.11.3 Risks, Limitations & Regulatory Considerations
  • 3.12 Gap analysis
  • 3.13 Patent / IP Landscape
  • 3.14 Medical Infrastructure Landscape
  • 3.15 Epidemiology / Disease Burden

Chapter 4. Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By Region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia-Pacific
      • 4.2.1.4 Latin America
      • 4.2.1.5 Middle East and Africa
    • 4.2.2 Market Concentration Analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Key developments
    • 4.5.1 Mergers & acquisitions
    • 4.5.2 Partnerships & collaborations
    • 4.5.3 New product launches
    • 4.5.4 Expansion plans and funding
  • 4.6 Company tier benchmarking
    • 4.6.1 Tier classification criteria & qualifying thresholds
    • 4.6.2 Tier positioning matrix by revenue, geography & innovation

Chapter 5. Market Estimates and Forecast, By Catheter Type, 2026-2035 ($ Million)

  • 5.1 Key trends
  • 5.2 Long-term hemodialysis catheters
  • 5.3 Short-term hemodialysis catheters

Chapter 6. Market Estimates and Forecast, By Product, 2026-2035 ($ Million)

  • 6.1 Key trends
  • 6.2 Tunnelled catheters
    • 6.2.1 Cuffed tunnelled catheters
    • 6.2.2 Non-cuffed tunnelled catheters
  • 6.3 Non-tunnelled catheters

Chapter 7. Market Estimates and Forecast, By Material, 2026-2035 ($ Million)

  • 7.1 Key trends
  • 7.2 Polyurethane
  • 7.3 Silicone

Chapter 8. Market Estimates and Forecast, By Tip Configuration, 2026-2035 ($ Million)

  • 8.1 Key trends
  • 8.2 Split-tip Catheters
  • 8.3 Step-tip Catheters
  • 8.4 Symmetric Catheters
  • 8.5 Other Tip Configurations

Chapter 9. Market Estimates and Forecast, By Lumen, 2026-2035 ($ Million)

  • 9.1 Key trends
  • 9.2 Double-lumen
  • 9.3 Single-lumen
  • 9.4 Triple-lumen

Chapter 10. Market Estimates and Forecast, By Region, 2026-2035 ($ Million)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Italy
    • 10.3.5 Spain
    • 10.3.6 Netherlands
    • 10.3.7 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 India
    • 10.4.3 Japan
    • 10.4.4 Australia
    • 10.4.5 South Korea
    • 10.4.6 Rest of Asia-Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
    • 10.5.4 Rest of Latin America
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE
    • 10.6.4 Rest of Middle East and Africa

Chapter 11. Company Profiles

  • 11.1 Global Player
    • 11.1.1 B. Braun
    • 11.1.2 Baxter
    • 11.1.3 Becton, Dickinson and Company (BD)
    • 11.1.4 Cook Medical
    • 11.1.5 Merit Medical
    • 11.1.6 Teleflex
    • 11.1.7 Vygon
    • 11.1.8 AngioDynamics
  • 11.2 Regional Player
    • 11.2.1 Amecath
    • 11.2.2 Bain Medical Equipment
    • 11.2.3 Delta Med
    • 11.2.4 Healthline Medical Products
    • 11.2.5 Medcomp
    • 11.2.6 Polymed
  • 11.3 Emerging Player
    • 11.3.1 Mozarc Medical
    • 11.3.2 ST Stone Medical